Masahiro Miyake Selected Research

Masahiro Miyake Research Topics

Disease

25	Macular Degeneration (Age-Related Maculopathy) 01/2024 - 07/2012
12	Glaucoma 01/2024 - 12/2014
12	Polypoidal Choroidal Vasculopathy 01/2024 - 07/2012
11	Myopia 11/2023 - 01/2013
8	Atrophy 11/2023 - 01/2013
6	Choroidal Neovascularization 09/2023 - 04/2012
4	Cataract (Cataracts) 01/2024 - 01/2013
3	Central Serous Chorioretinopathy 01/2023 - 11/2020
3	Retinal Detachment (Retinal Detachments) 01/2022 - 07/2012
2	Hemorrhage 11/2023 - 12/2020
2	Retinal Perforations 11/2023 - 01/2022
2	Atopic Dermatitis (Atopic Eczema) 10/2023 - 01/2021
2	Ganglion Cysts (Ganglion) 01/2015 - 12/2014
1	Corneal Diseases (Corneal Disease) 01/2024
1	Hypoxia (Hypoxemia) 01/2024
1	Obstructive Sleep Apnea 01/2024
1	Fibrosis (Cirrhosis) 11/2023
1	Retinal Arterial Macroaneurysm 11/2023
1	Epiretinal Membrane (Epiretinal Membranes) 07/2023
1	Vitreous Detachment (Posterior Vitreous Detachment) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Cerebral Small Vessel Diseases 01/2022
1	Cognitive Dysfunction 01/2022
1	Blister (Bulla) 12/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Keratoconus 01/2020
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2020
1	Cysts 01/2019
1	Chlamydophila Infections 03/2015
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Geographic Atrophy 11/2013
1	Papilledema 07/2012
1	Mental Disorders (Mental Disorder) 07/2003

Drug/Important Bio-Agent (IBA)

14	Retinaldehyde (Retinal)IBA 01/2024 - 12/2014
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 04/2012
11	Ranibizumab (Lucentis)FDA Link 11/2023 - 07/2012
9	afliberceptIBA 11/2023 - 11/2014
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 02/2015
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
3	N-acetyltryptophanamide (NATA)IBA 11/2023 - 01/2023
3	ras-GRF1 (ras GRF1)IBA 12/2020 - 11/2013
3	Complement Factor H (Factor H)IBA 11/2019 - 09/2013
2	faricimabIBA 01/2024 - 11/2023
2	SteroidsIBA 10/2023 - 01/2021
2	Ophthalmic Solutions (Eye Drops)IBA 01/2022 - 12/2020
2	Retinal Pigments (Pigments, Visual)IBA 01/2016 - 11/2013
1	AngiopoietinsIBA 11/2023
1	Vascular Endothelial Growth FactorsIBA 11/2023
1	Therapeutic UsesIBA 11/2023
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2023
1	GTP Phosphohydrolases (GTPases)IBA 11/2023
1	Laminin (Merosin)IBA 11/2023
1	Collagen Type IXIBA 11/2023
1	GATA5 Transcription FactorIBA 11/2023
1	CollagenIBA 11/2023
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2023
1	Verteporfin (Visudyne)FDA Link 06/2022
1	AdrenomedullinIBA 01/2022
1	Coffee FDA Link 05/2021
1	Pregnenolone Carbonitrile (PCN)IBA 11/2020
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 12/2019
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 11/2019
1	P-2 (P 2)IBA 01/2019
1	isopropyl unoprostone (Rescula)FDA Link 03/2017
1	CalciumIBA 03/2015
1	HDL CholesterolIBA 01/2015
1	Retinoic Acid 4-Hydroxylase (CYP26B1)IBA 10/2014
1	Fluorescein (Funduscein)FDA LinkGeneric 08/2014
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 08/2014
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	LipidsIBA 09/2013
1	Cholesterol Ester Transfer ProteinsIBA 09/2013
1	Complement Factor I (C3b Inactivator)IBA 06/2013
1	pigment epithelium-derived factorIBA 06/2013
1	Bevacizumab (Avastin)FDA Link 01/2013
1	Insulin-Like PeptidesIBA 01/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013
1	Clonazepam (Rivotril)FDA LinkGeneric 07/2003

Therapy/Procedure

7	Therapeutics 06/2022 - 05/2013
7	Intravitreal Injections 12/2021 - 01/2013
6	Photochemotherapy (Photodynamic Therapy) 01/2023 - 02/2015
3	Injections 01/2024 - 01/2019
3	Vitrectomy 11/2023 - 01/2022
3	Trabeculectomy (Trabeculoplasty) 10/2023 - 12/2021
3	Traction 07/2023 - 04/2016
2	Aftercare (After-Treatment) 01/2022 - 07/2012
1	Slit Lamp 01/2024
1	Vitreoretinal Surgery 12/2023
1	Operative Surgical Procedures 10/2023
1	Corneal Transplantation (Keratoplasty) 01/2020